Metabolic Risk Panel

What it measures

• TriglyceridesLOINC 2571-8
• Cholesterol, TotalLOINC 2093-3
• HDL CholesterolLOINC 2085-9
• LDL-CholesterolLOINC 13457-7
• Chol/HDLC RatioLOINC 9830-1
• Non HDL CholesterolLOINC 43396-1
• Hemoglobin A1CLOINC 4548-4
• Apolipoprotein BLOINC 1884-6
• Insulin, Intact, LC/MS/MSLOINC 89324-8
• C-Peptide, LC/MS/MSLOINC 1986-9
• Insulin Resistance ScoreLOINC 92845-7

Before the visit

If a cholesterol measurement is to be performed along with triglycerides, but not part of a lipid panel, then the patient should be fasting 9-12 hours prior to collection. If the cholesterol is ordered as part of a lipid panel, then a fasting sample is not required. The assay manufacturer Beckman Coulter advises: N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been determined to interfere with assays for cholesterol and uric acid where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hours and a third dose of 100 mg/kg administered over 16 hours.

Specimen

Specimen

2.5 mL serum and 1 mL whole blood collected in an EDTA (lavender-top) tube

Minimum volume

1.4 mL serum • 0.5 mL whole blood

Temperature

Refrigerated (cold packs)

Billing

CPT 80061, 82172, 83036, 83525, 84681